Type I interferonopathies—an expanding disease spectrum of immunodysregulation

Seminars in Immunopathology

Volumn 37, Issue 4, 2015, Pages 349-357

  Lee Kirsch, Min Ae ^a   Wolf, Christine ^a   Kretschmer, Stefanie ^a   Roers, Axel ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aicardi Gouti res syndrome; Autoimmunity; Autoinflammation; Familial chilblain lupus; Systemic lupus erythematosus; Type I interferon; Type I interferonopathies

Indexed keywords

INTERFERON; INTERFERON STIMULATED PROTEIN 15; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR;

ACP5 GENE; ADAR GENE; AICARDI GOUTIERES SYNDROME; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; CHRONIC ATYPICAL NEUTROPHILIC DERMATOSIS WITH LIPODYSTROPHY AND ELEVATED TEMPERATURE; DISEASE SEVERITY; DNASE1 GENE; DNASE1L3 GENE; FAMILIAL CHILBLAIN LUPUS; GENE; HUMAN; IFIH1 GENE; IMMUNE DYSREGULATION; IMMUNE RESPONSE; INTERFERON STIMULATED PROTEIN 15 DEFICIENCY; INTERFERONOPATHY TYPE 1; ISG15 GENE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PSMB8 GENE; RETINAL VASCULOPATHY WITH CEREBRAL LEUKODYSTROPHY; REVIEW; RIGI GENE; RNASEH2A GENE; RNASEH2B GENE; RNASEH2C GENE; SAMHD1 GENE; SIGNAL TRANSDUCTION; SINGLETON MERTEN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SPONDYLOENCHONDRODYSPLASIA; STING ASSOCIATED VASCULOPATHY INFANTILE ONSET; STING GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREX1 GENE; VASCULAR DISEASE; ANIMAL; AUTOIMMUNE DISEASES; DISEASE PREDISPOSITION; GENETICS; HEREDITARY AUTOINFLAMMATORY DISEASES; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; HEREDITARY AUTOINFLAMMATORY DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTERFERON TYPE I; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84943364223     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0500-x     Document Type: Review

References (79)

1. Stetson DB, Medzhitov R (2006) Type I interferons in host defense. Immunity 25:373-381
2. Taniguchi T, Takaoka A (2001) Aweak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2:378-386
3. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835
4. O’Neill LA, Golenbock D, Bowie AG (2013) The history of Tolllike receptors—redefining innate immunity. Nat Rev Immunol 13: 453-460
5. Atianand MK, Fitzgerald KA (2013) Molecular basis of DNA recognition in the immune system. J Immunol 190:1911-1918
6. Kawai T, Takahashi K, Sato S et al (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988
7. Hornung V, Ellegast J, Kim S et al (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997
8. Goubau D, Schlee M, Deddouche S et al (2014) Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 514:372-375
9. Ablasser A, Bauernfeind F, Hartmann G et al (2009) RIG-Idependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10:1065-1072
10. Chiu YH, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-591
11. Sun L, Wu J, Du F et al (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791
12. Wu J, Sun L, Chen X et al (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-830
13. Xiao TS, Fitzgerald KA (2013) The cGAS-STING pathway for DNA sensing. Mol Cell 51:135-139
14. Platanias LC (2005) Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 5:375-386
15. Lovgren T, Eloranta ML, Bave U et al (2004) Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50:1861-1872
16. Napirei M, Karsunky H, Zevnik B et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177-181
17. Kawane K, Ohtani M, Miwa K et al (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998-1002
18. Crow YJ (2011) Type I interferonopathies: a novel set of inborn errors of immunity. Ann N YAcad Sci 1238:91-98
19. Aicardi J, Goutieres F (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 15:49-54
20. Lebon P, Badoual J, Ponsot G et al (1988) Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J Neurol Sci 84:201-208
21. Tolmie JL, Shillito P, Hughes-Benzie R et al (1995) The Aicardi- Goutieres syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J Med Genet 32:881-884
22. Ramantani G, Kohlhase J, Hertzberg C et al (2010) Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome. Arthritis Rheum 62:1469-1477
23. Rice GI, Forte GM, Szynkiewicz M et al (2013) Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 12:1159-1169
24. Vogt J, Agrawal S, Ibrahim Z et al (2013) Striking intrafamilial phenotypic variability in Aicardi-Goutieres syndrome associated with the recurrent Asian founder mutation in RNASEH2C. Am J Med Genet A 161A:338-342
25. Tüngler V, Schmidt F, Hieronimus S et al (2014) Phenotypic variability in a family with Aicardi-Goutières syndrome due to the common A177T RNASEH2B mutation. Case Rep Clin Med 3: 153-156
26. Crow YJ, Hayward BE, Parmar R et al (2006)Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi- Goutieres syndrome at the AGS1 locus. Nat Genet 38:917-920
27. Chowdhury D, Beresford PJ, Zhu P et al (2006) The exonuclease TREX1 is in the SETcomplex and acts in concertwithNM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 23:133-142
28. Yang YG, Lindahl T, Barnes DE (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873-886
29. Stetson DB, Ko JS, Heidmann T et al (2008) Trex1 prevents cellintrinsic initiation of autoimmunity. Cell 134:587-598
30. Gall A, Treuting P, Elkon KB et al (2012) Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36:120-131
31. Ablasser A, Hemmerling I, Schmid-Burgk JL et al (2014) TREX1 deficiency triggers cell-autonomous immunity in a cGASdependent manner. J Immunol 192:5993-5997
32. Rice G, Newman WG, Dean J et al (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi- Goutieres syndrome. Am J Hum Genet 80:811-815
33. Tungler V, Silver RM, Walkenhorst H et al (2012) Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol 167:212-214
34. Crow YJ, Leitch A, Hayward BE et al (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38: 910-916
35. Reijns MA, Rabe B, Rigby RE et al (2012) Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149:1008-1022
36. Hiller B, Achleitner M, Glage S et al (2012)Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 209:1419-1426
37. Sparks JL, Chon H, Cerritelli SM et al (2012) RNase H2-initiated ribonucleotide excision repair. Mol Cell 47:980-986
38. Kim N, Huang SN, Williams JS et al (2011) Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science 332: 1561-1564
39. Kind B, Muster B, Staroske W et al (2014) Altered spatio-temporal dynamics of RNase H2 complex assembly at replication and repair sites in Aicardi-Goutieres syndrome. Hum Mol Genet 23:5950-5960
40. Gunther C, Kind B, Reijns MA et al (2015) Defective removal of ribonucleotides fromDNApromotes systemic autoimmunity. J Clin Invest 125:413-424
41. Goldstone DC, Ennis-Adeniran V, Hedden JJ et al (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-382
42. Hrecka K, Hao C, Gierszewska M et al (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661
43. Laguette N, Sobhian B, Casartelli N et al (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657
44. Lahouassa H, Daddacha W, Hofmann H et al (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223-228
45. Goncalves A, Karayel E, Rice GI et al (2012) SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardigoutieres syndrome-associated mutations. Hum Mutat 33:1116-1122
46. Tungler V, Staroske W, Kind B et al (2013) Single-stranded nucleic acids promote SAMHD1 complex formation. J MolMed (Berl) 91: 759-770
47. Beloglazova N, Flick R, Tchigvintsev A et al (2013) Nuclease activity of the human SAMHD1 protein implicated in the Aicardi- Goutieres syndrome and HIV-1 restriction. J Biol Chem 288:8101-8110
48. Ryoo J, Choi J, Oh C et al (2014) The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 20:936-941
49. Cribier A, Descours B, Valadao AL et al (2013) Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 3:1036-1043
50. Kretschmer S, Wolf C, Konig N et al (2014) SAMHD1 prevents autoimmunity by maintaining genome stability. Ann Rheum Dis
51. Rice GI, Kasher PR, Forte GM et al (2012) Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 44:1243-1248
52. Wang Q, Khillan J, Gadue P et al (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765-1768
53. Mannion NM, Greenwood SM, Young R et al (2014) The RNAediting enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9:1482-1494
54. Rice GI, Del Toro DY, Jenkinson EM et al (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503-509
55. Richards A, van den Maagdenberg AM, Jen JC et al (2007) Cterminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39:1068-1070
56. Schuh E, Ertl-Wagner B, Lohse P et al (2015) Multiple sclerosislike lesions and type I interferon signature in a patient with RVCL. Neurol Neuroimmunol Neuroinflamm 2:e55
57. Lee-Kirsch MA, Gong M, Schulz H et al (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet 79:731-737
58. Gunther C, Hillebrand M, Brunk J et al (2013) Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol 69:e179-e181
59. Lee-Kirsch MA, Chowdhury D, Harvey S et al (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med 85:531-537
60. Dale RC, Gornall H, Singh-Grewal D et al (2010) Familial Aicardi- Goutieres syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. Am J Med Genet A 152A: 938-942
61. Liu Y, Jesus AA, Marrero B et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507-518
62. Jeremiah N, Neven B, Gentili M et al (2014) Inherited STINGactivating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124:5516-5520
63. Harley IT, Kaufman KM, Langefeld CD et al (2009) Genetic susceptibility to SLE: new insights from fine mapping and genomewide association studies. Nat Rev Genet 10:285-290
64. Baechler EC, Batliwalla FM, Karypis G et al (2003) Interferoninducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100:2610-2615
65. Lee-Kirsch MA, Gong M, Chowdhury D et al (2007) Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065-1067
66. Namjou B, Kothari PH, Kelly JA et al (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12:270-279
67. Yasutomo K, Horiuchi T, Kagami S et al (2001) Mutation of DNAS E1 in people with systemic lupus erythematosus. Nat Genet 28: 313-314
68. Al-Mayouf SM, Sunker A, Abdwani R et al (2011) Loss-offunction variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43:1186-1188
69. Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22:431-456
70. Renella R, Schaefer E, LeMerrer M et al (2006) Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder. Am J Med Genet A 140:541-550
71. Briggs TA, Rice GI, Daly S et al (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 43:127-131
72. Lausch E, Janecke A, Bros M et al (2011) Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 43:132-137
73. Gay BB Jr, Kuhn JP (1976) A syndrome of widened medullary cavities of bone, aortic calcification, abnormal dentition, and muscular weakness (the Singleton-Merten syndrome). Radiology 118:389-395
74. Rutsch F, MacDougall M, Lu C et al (2015) A specific IFIH1 gainof- function mutation causes Singleton-Merten syndrome. Am J Hum Genet 96:275-282
75. Jang MA, Kim EK, Now H et al (2015) Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet 96:266-274
76. Bogunovic D, Byun M, Durfee LA et al (2012) Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337:1684-1688
77. Zhang X, Bogunovic D, Payelle-Brogard B et al (2015) Human intracellular ISG15 prevents interferon-alpha/beta overamplification and auto-inflammation. Nature 517:89-93
78. Liu Y, Ramot Y, Torrelo A et al (2012) Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64:895-907
79. Basler M, Kirk CJ, Groettrup M (2013) The immunoproetasome iin antigen processing and other immunolgical functions. Curr Opin Immunol 25:74-80